Market Access Consulting > Market Access Plan your success path Market Access entry preparation is critical to your success. The Nordic region is a highly regulated and tax paid on/off market. There simply are no other options than doing things the right way. Get the required guidance and knowledge to focus your efforts and prioritise your resources. When you choose Signum, you gain access to a team of experienced and knowledgeable professionals who have deep understandings of Nordic health care systems. You also gain access to multiple data solutions that can help you build a strong case and plan for success in Market Access. Navigate the Nordic markets Increased centralization and focus on health economics and cost optimization has created intense pressure on the pharmaceutical industry. Navigating the diverse processes in the Nordic countries can be overwhelming and block your route to success. At Signum, we make it our job to understand the Nordic market and help others understand what needs to be done in order to succeed with their Market Access and sell in this highly regulated region. Stakeholder management From The Danish Medicines Council to The Danish Medical Agency for Reimbursement, to Amgros and Danish Regions: the list of Danish medical authorities can seem endless. Prioritise your networking efforts to target the right people at the right time to succeed with your Market Access. This is how we help you Atlas reports and workshop Gain in-depth insight into the public sector’s agreement structures The Danish Medicines Council has recommended your new drug as standard treatment in hospitals. What now? Learn how you can play an active role in the implementation of your drug at the individual hospital wards. With the Atlas reports and consultancy from Signum, you will gain in-depth insight into the public sector’s agreement structures for the implementation of health and new treatments (including drugs). Get your atlas report now “Having the right dialogue with public decisionmakers can often mean the difference between success and failure for my clients. Substance is what matters. I have inside experience in how public decision-making works, and I use this information to guide my clients, case-by-case.” Ulla Ege Johansen Chief Advisor Market Access Plan your market access wisely We guide you to a smoother Market Access process, including how to communicate successfully with The Danish Medicine Council. This is how we help you For more information, please contact Ulla Ege Johansen Chief Advisor, Market Access uej@signumlifescience.com +45 22 746 019 Frequently asked questions Click on the arrow to expand How does effective market access preparation reduce risk when entering the Nordic healthcare systems? Market Access preparation ensures you understand the highly regulated, tax-paid, on/off-market structure of the Nordics. By aligning early with local requirements, you reduce delays, avoid procedural missteps, and ensure your efforts and resources are focused on actions that truly influence approval and uptake. What strategic advantages does market access consulting provide in countries with an increasing focus on health economics? Nordic authorities are placing stronger emphasis on cost optimization, value demonstration, and health economics. Expert consulting helps you frame your product in terms of real-world value, build a stronger case for reimbursement, and satisfy the health economic requirements that shape funding decisions. How can understanding public-sector agreement structures improve a product’s uptake in Nordic hospitals? Access to Atlas reports detailing public-sector agreement structures helps you understand how new treatments are implemented across hospital wards. This clarity allows you to anticipate adoption barriers, engage decision-makers more effectively, and increase the likelihood of successful adoption. Why is stakeholder management essential for achieving market access success in Denmark and the wider Nordic region? Multiple authorities, including the Danish Medicines Council, Danish Medical Agency for Reimbursement, Amgros, and Danish Regions, influence market decisions. Knowing which stakeholders to engage, when to engage them, and what they expect significantly increases your chances of success. How does having the “right” dialogue with authorities influence market access success? Regulators value evidence, clarity, and substance. Having the “right” dialogue means presenting data that aligns with their expectations, answering the questions they prioritize, and demonstrating awareness of public-sector decision logic. This can be the difference between approval and rejection. Why should you avoid a generic market access approach in the Nordics? The Nordic region may look unified, but differences in processes, incentives, and adoption structures mean that using a generic approach leads to misalignment and delays. A tailored strategy prevents costly errors and ensures your efforts are relevant to each country’s specific pathway. Clear examples of what we can help you with Case Launching companion diagnostics in the Nordics Learn how we applied local insights to launch companion diagnostics in the Nordics, tackling market access, reimbursement, and healthcare challenges. Inspire me Case Securing gene therapy market access in Denmark Learn how we secured market access for a gene therapy medicine by tackling limited data, high costs, and bottlenecks in the Danish healthcare system. Inspire me Case Securing vaccine market access in the Nordics Learn how we helped our client secure market access for their vaccine in the Nordics through regulatory compliance and insights into funding mechanisms. Inspire me
